The changing use of disease-modifying anti-rheumatic drugs in individuals with RA from The General Practice Research Database (GPRD) the changing use of disease-modifying anti-rheumatic drugs for RA from The General Practice Research Database

Chi tiết về thư mục
Những tác giả chính:	Edwards, C, Arden, N, Van Staa, T, Reading, I, Saperia, J, Fisher, D, Cooper, C
Định dạng:	Conference item
Được phát hành:	2005

The changing use of disease-modifying anti-rheumatic drugs in individuals with RA from the general practice research database (GPRD).
Bằng: Edwards, C, et al.
Được phát hành: (2004)

The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.
Bằng: Edwards, C, et al.
Được phát hành: (2005)

Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis
Bằng: Arvind Chopra, et al.
Được phát hành: (2018-07-01)

Development of an in-vitro rheumatoid arthritis (RA) model and its application in anti-rheumatic drug testing
Bằng: Tan, Kian Siong
Được phát hành: (2016)

Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
Bằng: Ellen Wright, et al.
Được phát hành: (2012-01-01)

Use of disease-modifying anti-rheumatic drugs in the therapy of osteoarthritis
Bằng: S. G. Anikin, et al.
Được phát hành: (2019-05-01)

Disease Modifying Anti-Rheumatic Drugs: Review on Pregnancy and Lactation
Bằng: Tsz-Yuen wu, et al.
Được phát hành: (2019-07-01)

Implications of the problem orientated medical record (POMR) for research using electronic GP databases: a comparison of the Doctors Independent Network Database (DIN) and the General Practice Research Database (GPRD)
Bằng: Caine Steve, et al.
Được phát hành: (2003-09-01)

STRONTIUM RANELATE AND RISK OF VENOUS THROMBOEMBOLISM (VTE): AN UPDATE OF A RETROSPECTIVE COHORT STUDY IN THE UK GENERAL PRACTICE RESEARCH DATABASE (GPRD)
Bằng: Cooper, C, et al.
Được phát hành: (2012)

Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs
Bằng: CUI Hanshu, et al.
Được phát hành: (2025-01-01)

Recent Advancements in Drug Delivery of Sinomenine, A Disease-Modifying Anti-Rheumatic Drug
Bằng: Xin Chen, et al.
Được phát hành: (2022-12-01)

Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs
Bằng: Iván Arias de la Rosa, et al.
Được phát hành: (2021-10-01)

Costs of treatment with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in rheumatic diseases – data from the Romanian Registry of Rheumatic Diseases
Bằng: Catalin Codreanu, et al.
Được phát hành: (2020-03-01)

The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
Bằng: Daniel H. Solomon, et al.
Được phát hành: (2021-01-01)

Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees
Bằng: James J. Tsakas, et al.
Được phát hành: (2022-10-01)

The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
Bằng: Nilüfer Alpay Kanıtez, et al.
Được phát hành: (2022-10-01)

Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management
Bằng: Sukhbir Singh, et al.
Được phát hành: (2024-02-01)

Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth
Bằng: Shivshankar Thanigaimani, et al.
Được phát hành: (2022-09-01)

An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis
Bằng: Sara Tenti, et al.
Được phát hành: (2023-03-01)

Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
Bằng: Andrea Giachi, et al.
Được phát hành: (2022-10-01)

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
Bằng: Fabiola Atzeni, et al.
Được phát hành: (2021-08-01)

Treatment of axial spondyloarthritis patients with biologic disease-modifying anti-rheumatic drugs in 2022 - data from the Romanian Registry of Rheumatic Diseases
Bằng: Laura Muntean, et al.
Được phát hành: (2023-12-01)

Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS) in rheumatic arthritis (RA): a real-world comparative assesment
Bằng: Prats-Uribe, A, et al.
Được phát hành: (2020)

Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?
Bằng: Nadia Emi Aikawa, et al.
Được phát hành: (2011-01-01)

Serum anti-cyclic citrullinated peptide antibodies before and after treatment by disease-modifying anti-rheumatic drugs
Bằng: Nasrin Moghimi, et al.
Được phát hành: (2014-06-01)

Temporal Trends In The Prescribing Of Disease Modifying Anti-Rheumatic Drugs For Rheumatoid Arthritis and The Impact Of Guidelines.
Bằng: Wallace, G, et al.
Được phát hành: (2013)

Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
Bằng: Chun-Yu Lin, et al.
Được phát hành: (2023-07-01)

Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
Bằng: David Simon, et al.
Được phát hành: (2019-07-01)

Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database
Bằng: Hata T, et al.
Được phát hành: (2022-08-01)

Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors
Bằng: Kotaro Matsumoto, et al.
Được phát hành: (2023-05-01)

Data from the Romanian Registry of Rheumatic Diseases for patients with psoriatic arthritis treated with biologic disease-modifying anti-rheumatic drugs during 2019
Bằng: Andra Balanescu, et al.
Được phát hành: (2020-06-01)

The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.
Bằng: Cooper, C, et al.
Được phát hành: (2010)

Adverse events from the Romanian Registry of Rheumatic Diseases in patients treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs during 2019
Bằng: Corina Mogosan, et al.
Được phát hành: (2020-03-01)

Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis
Bằng: Kate Tokareva, et al.
Được phát hành: (2025-01-01)

Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis
Bằng: I. M. Marusenko, et al.
Được phát hành: (2019-03-01)

Comparative analysis of multiorgan toxicity induced by long term use of disease modifying anti-rheumatic drugs.
Bằng: Tamseela Mumtaz, et al.
Được phát hành: (2023-01-01)

Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
Bằng: Junyu Fan, et al.
Được phát hành: (2023-09-01)

Treatment of rheumatoid arthritis with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in 2022 – real-world data from the Romanian Registry of Rheumatic Diseases
Bằng: Elena Rezus, et al.
Được phát hành: (2023-09-01)

Data from the Romanian Registry of Rheumatic Diseases for patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs during 2019
Bằng: Catalin Codreanu, et al.
Được phát hành: (2020-03-01)

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope
Bằng: Mercer, L, et al.
Được phát hành: (2024)

The changing use of disease-modifying anti-rheumatic drugs in individuals with RA from The General Practice Research Database (GPRD) the changing use of disease-modifying anti-rheumatic drugs for RA from The General Practice Research Database

Những quyển sách tương tự

Những quyển sách tương tự